Aziyo biologics announces record annual net sales in preliminary (unaudited) fourth quarter and full year 2022 topline results

Silver spring, md., jan. 09, 2023 (globe newswire) -- aziyo biologics, inc. (nasdaq: azyo) (“aziyo”), a biologics company with a portfolio of regenerative products aimed at improving compatibility between medical devices and the patients they treat, today announced preliminary (unaudited) net sales results for its fourth quarter and full year ended december 31, 2022.
AZYO Ratings Summary
AZYO Quant Ranking